ARCHETYPE Enrollment in intravitreal anti-VEGF therapy for wet AMD (openEHR-EHR-EVALUATION.long_term_process_enrollment-antiVEGF_AMD.v0)

ARCHETYPE IDopenEHR-EHR-EVALUATION.long_term_process_enrollment-antiVEGF_AMD.v0
ConceptEnrollment in intravitreal anti-VEGF therapy for wet AMD
DescriptionManages the enrollment of patients in intravitreal anti-VEGF therapy to treat wet AMD.
UseIt can be used for enrollment of new patients into the cycles of anti-VEGF injections to treat wet AMD, but also it is possible to evaluate already registered patients to reconsider the continuity of their treatment at a given time.
MisuseMost of archetypes are focused on register acute episodes identified on clinical environment. Conversely, this one is aimed at periodically review a decision made about a protracted healthcare process (for instance, a therapeutic decision for a chronic condition that requires regular treatment). Thus, this archetype is not intended for registering decisions about occasional actions.
PurposeRecord a contribution to the decision of admittance of a patient in the process of wet AMD treatment by intravitreal anti-VEGF periodical injections.
References
Copyright© openEHR Foundation
AuthorsAuthor name: Aitor Eguzkitza
Organisation: Universidad Pública de Navarra - Complejo Hospitalario de Navarra
Email: aitor.eguzkiza@unavarra.es
Date originally authored: 2015-06-24
Other Details LanguageAuthor name: Aitor Eguzkitza
Organisation: Universidad Pública de Navarra - Complejo Hospitalario de Navarra
Email: aitor.eguzkiza@unavarra.es
Date originally authored: 2015-06-24
Other Details (Language Independent)
  • Licence: This work is licensed under the Creative Commons Attribution-ShareAlike 3.0 License. To view a copy of this license, visit http://creativecommons.org/licenses/by-sa/3.0/.
  • Custodian Organisation: openEHR Foundation
  • Original Namespace: org.openehr
  • Original Publisher: openEHR Foundation
  • Custodian Namespace: org.openehr
  • MD5-CAM-1.0.1: 5B07C7E1EB58430EEF14CA0485911F66
  • Build Uid: cc8da233-b399-4189-bb59-1e017fd71d17
  • Revision: 0.0.1-alpha
Keywordschronic, admittance, wet amd, anti-vegf
Lifecyclein_development
UID36f8f3b8-572e-4337-8a11-810b8f657ba8
Language useden
Citeable Identifier1013.1.2105
Revision Number0.0.1-alpha
data
Healthcare processHealthcare process: Identification of the healthcare process about which the enrollment of a specific patient is discussed.
DescriptionDescription: Narrative description about the healthcare service to which the patient has been proposed for admittance.
AdmittanceAdmittance: If true, the patient meets the criteria required to be inscribed in the healthcare process.
Assumed value: true
CriteriaCriteria: Different criteria considered to make a decision with regard to patient's admittance into the healthcare process.
  • Very low VA [Visual acuity on first clinical encounter below 0.1 in decimal scale.]
  • Healed lesions [Identified signs of previous treatments such as photodynamic therapy, laser photocoagulation scars, or any vitreoretinal operative procedure.]
  • Multimorbidity [Coexistence of additional alterations on the retina causative of visual impairment.]
  • Reaction to anti-VEGF [Establishment or suspicion of any reaction due to hypersensitivity to anti-VEGF agents used in intravitreal injections.]
  • VA decrease [Visual acuity decreased for three consecutive reviews below 0.1 in decimal scale.]
  • Morphologic deterioration [Progressive deterioration of the morphology of the lesion.]
protocol
Date decisionDate decision: Date at which decision was made about the enrollment or exclusion of the patient with regard to the healthcare process.
Full Date and Time
Decision reviewDecision review: Next revision date scheduled for the current decision of enrollment.
Full Date
Other contributorsLuis Serrano, Universidad Pública de Navarra (UPNA), lserrano@unavarra.es
José Andonegui, Hospital de Navarra, jose.andonegui.navarro@cfnavarra.es
Jesús D. Trigo, Universidad Pública de Navarra (UPNA), jesusdaniel.trigo@unavarra.es
Translators